SHILPA MEDICARE
Back to Income Statement
|
SHILPA MEDICARE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹78 Cr | ₹32 Cr | ₹-32 Cr | ₹61 Cr | ₹148 Cr |
What is the latest Consolidated Net Profit of SHILPA MEDICARE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹78 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹-32 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹148 Cr |
How is Consolidated Net Profit of SHILPA MEDICARE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹78 Cr | 145.62 | |
| Mar2025 | ₹32 Cr | Positive | |
| Mar2024 | ₹-32 Cr | Negative | |
| Mar2023 | ₹61 Cr | -58.95 | |
| Mar2022 | ₹148 Cr | - | |
Compare Consolidated Net Profit of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹19,855.4 Cr | -5.4% | 5.6% | 170.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | -5.4% |
5.6% |
170.2% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses